(0.06%) 5 472.67 points
(0.10%) 39 151 points
(0.34%) 17 779 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.60
(0.20%) $28.93
(3.50%) $1 020.90
(0.28%) $0.936
(0.68%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia...
Stats | |
---|---|
今日成交量 | 19.05M |
平均成交量 | 9.38M |
市值 | 4.34M |
EPS | $0.130 ( Q1 | 2024-05-23 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0399 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-31 | Moch Kenneth I | Buy | 200 000 | Ordinary Shares |
2024-01-31 | Wills Stephen T | Buy | 200 000 | Ordinary Shares |
2024-01-31 | Tomasello Shawn | Buy | 200 000 | Ordinary Shares |
2024-01-31 | Adams Julian | Buy | 200 000 | Ordinary Shares |
2024-01-31 | Simantov Ronit | Buy | 480 319 | Ordinary Shares |
INSIDER POWER |
---|
95.68 |
Last 90 transactions |
Buy: 8 073 627 | Sell: 418 674 |
音量 相关性
Gamida Cell Ltd 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Gamida Cell Ltd 相关性 - 货币/商品
Gamida Cell Ltd 财务报表
Annual | 2023 |
营收: | $1.78M |
毛利润: | $-1.69M (-94.96 %) |
EPS: | $-0.570 |
FY | 2023 |
营收: | $1.78M |
毛利润: | $-1.69M (-94.96 %) |
EPS: | $-0.570 |
FY | 2022 |
营收: | $0 |
毛利润: | $-440 000 (0.00 %) |
EPS: | $-2.42 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Gamida Cell Ltd
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, a natural killer cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. In addition, the company is developing NK cell pipeline comprising GDA-301, GDA-401, GDA-501, and GDA-601 to treat hematologic malignancies and solid tumors. The company was founded in 1998 and is headquartered in Jerusalem, Israel.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。